[Pharm-policy] Letter from PhRMA to Members of the U.S. Congress: "Global Partnerships, Uniting to Build a Healthier Tomorrow"

Thiru Balasubramaniam thiru@cptech.org
Mon, 21 Aug 2000 12:28:32 -0400


Thanks to Tate for this information.

Thiru


----------------------------------------------------
I'm writing to share a letter Rep. Berry received from PhRMA today.  I
assume they sent it to all members of Congress.  Along with it, they
sent a high quality oversized color publication titled Global
Partnerships, Uniting to Build a Healthier Tomorrow.  The publication is
available from their website at the following address:
http://www.world.phrma.org/partnerships.html

Not so amazingly, it doesn't mention Glaxco's recent efforts to end
access to charitable donations of AIDS medicines others were making to
Ghana.

-tate


Note:  The letter below was scanned in and it is possible it contains
minor transposition errors.
--------------------letter-------------------------
PhRMA
Shannon Herzfeld
Senior Vice President
International

August 15, 2000

The Honorable Marion Berry
U.S. House of Representatives
1113 Longworth House Office Building
Washington, DC 20515-0401

Dear Representative Berry:

The pharmaceutical industry is dedicated to improving international
public health and lightening the load of disease worldwide.

Many people aren't aware of the pharmaceutical industry's many programs
and projects overseas. Our industry has contributed more than $1 billion
since 1996 in cash grants, medicines, medical supplies and education
campaigns throughout the developing world.

To describe these efforts more fully we have enclosed a copy of "Global
Partnerships: Uniting to Build a Healthier Tomorrow."

To carry out philanthropic activities on a wide scale, we work closely
with more than 50 international partners, including many of the
best-known, most prestigious public health organizations in the world,
from UNICEF and Project Hope to UNAIDS and the World Health
Organization.

Many of our companies have made major commitments to attack or eradicate
disabling diseases such as river blindness, leprosy, HIV/AIDS and
sleeping sickness. Others carry out programs on a smaller scale, but
still make a big difference in people's lives. We're there in hospitals
and clinics around the world. We work to find treatments and cures.

These humanitarian efforts overseas often attract little or no attention
here at home. That's why we have pulled this information together to
better inform opinion leaders like yourself that for decades, our
industry has been on the front lines of the global fight against
disease.

You can find out more about our industry's charitable and humanitarian
programs by visiting our web site at www.world.phrma.org. If we can
provide any additional information or answer any questions you may have,
please don't hesitate to contact me.

Sincerely,
/s/
Shannon Herzfeld



Pharmaceutical Research and Manufacturers of America

1100 Fifteenth Street, NW, Washington, DC 20005 
* Tel: 202-835-3400 - FAX: 202-835-3414 * 
E-Mail: sherzfeld@phrma.org